ArticleLancet regional health. Americas2025

Dapagliflozin for the treatment of heart failure with reduced ejection fraction in Brazil: a cost-effectiveness analysis.

Marcio Coutinho Xavier Naves et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.